Skip to content Skip to footer
Subscribe Now

CXO TALKS

CXO Talks Podcast | Building Smarter Biotech: Venkat Nelabhotla, CEO of Vyome Holdings, on Driving Innovation Across the US–India Corridor
Shots: In a thought-provoking conversation with PharmaShots CXO Talks, Venkat Nelabhotla, Co-Founder, President & CEO of Vyome Holdings, discussed how disciplined execution, strategic capital allocation, and focused innovation are shaping the company's approach to developing therapies for high unmet medical needs while strengthening the US–India biotech innovation corridor. Venkat highlighted Vyome's strategy of leveraging drug…
July 22, 2026
CXO Talks Podcast | The Road to Acquisition: Oncolytics’ CEO Jared Kelly on Clinical Data, IP & Pharma Partnerships
Shots: In an engaging conversation with PharmaShots CXO Talks, Jared Kelly, CEO & Director of Oncolytics Biotech, shared insights from his experience leading corporate strategy at Ambrx and contributing to its $2B acquisition by Johnson & Johnson, offering a practical perspective on what makes biotech companies attractive acquisition targets. Kelly explained why successful biotech acquisitions…
June 24, 2026
PharmaShots CXO Talks | Women’s History Month Special: A Conversation with Dr. Emanuela Offidani of Tris Pharma
Shots: Dr. Emanuela Offidani explains how ADHD is increasingly recognized as a lifelong condition affecting both children and adults. She highlights that symptoms can differ across genders and are often underdiagnosed in women due to less visible hyperactivity and more internalized symptoms such as inattention and emotional dysregulation. The conversation explores how Tris Pharma is…
March 26, 2026
CXO Talks: Vikas Sharma Reveals QurAlis’ Bold Vision for the Future of Neuroscience 
In this episode of CXO Talks, PharmaShots speaks with Vikas Sharma, Chief Business Officer at QurAlis, a biotech company leading the development of precision medicines for neurodegenerative diseases  Vikas discusses the company’s FlexASO platform, a next-generation RNA-targeting technology that tackles the root causes of neurological diseases  Vikas also highlights QurAlis’ lead candidates, QRL-201 and QRL-101,…
November 10, 2025
Rick Modi from Affinia Therapeutics in a Stirring Dialogue Exchange with PharmaShots
CXO Talks: Rick Modi from Affinia Therapeutics in a Stirring Dialogue Exchange with PharmaShots
Shots: In this episode of the CXO Talks podcast, PharmaShots speaks with Rick Modi, CEO at Affinia Therapeutics Driven by cutting-edge innovation, Affinia is pioneering and re-imagining adeno-associated virus serotype 9 (AAV9), a gene therapy delivery method for conditions affecting cardiac muscle, skeletal muscle, and the central nervous system Rick articulates the diagnostic and therapeutic…
September 8, 2025
CXO Talks: Thomas Chalberg & Annahita Keravala from Genascence in a Candid Conversation with PharmaShots
Shots: PharmaShots speaks with Thomas Chalberg, Founder and CEO of Genascence Corporation, and Annahita Keravala, Founder and CSO of Genascence Corporation Thomas and Annahita speak eloquently about Genascence's current lead program, GNSC-001, for osteoarthritis of the knee, and shed light on the unmet medical needs in the disease The duo highlighted the safety and tolerability…
August 11, 2025
CXO Talks: Tim O’Connell from Emtelligent in a Striking Conversation with PharmaShots
Shots:  In this episode of the CXO Talks podcast, PharmaShots spoke with Tim O’Connell, CEO of Emtelligent, a next-generation medical AI company  Tim highlights Emtelligent’s inspiring journey to becoming a leader in a clinical-grade NLP company focused on transforming unstructured data to actionable insights at an enterprise scale  Emtelligent leverages the power of medical records…
June 9, 2025
Load more